Cancer nanomedicine: is targeting our target?

Twan Lammers; Fabian Kiessling; Marianne Ashford; Wim Hennink; Daan Crommelin; Gerrit Storm

doi:10.1038/natrevmats.2016.69

Cancer nanomedicine: is targeting our target?

Twan Lammers, Fabian Kiessling, Marianne Ashford, Wim Hennink, Daan Crommelin, Gerrit Storm

Research output: Contribution to journal › Article › Academic › peer-review

143 Citations (Scopus)

92 Downloads (Pure)

Abstract

Nanomedicine may have a delivery problem. Rigorous, realistic and holistic rethinking is needed to improve nanomedicine performance and increase patient benefit.

Original language	English
Article number	16069
Journal	Nature materials
Volume	1
Issue number	9
DOIs	https://doi.org/10.1038/natrevmats.2016.69
Publication status	Published - 7 Sep 2016

Keywords

METIS-320803
IR-103724

Access to Document

10.1038/natrevmats.2016.69

Lammers2016cancerAccepted author version, 18.2 KB

Cite this

@article{31bd48ee90d94ac4b9515b06d6115620,

title = "Cancer nanomedicine: is targeting our target?",

abstract = "Nanomedicine may have a delivery problem. Rigorous, realistic and holistic rethinking is needed to improve nanomedicine performance and increase patient benefit.",

keywords = "METIS-320803, IR-103724",

author = "Twan Lammers and Fabian Kiessling and Marianne Ashford and Wim Hennink and Daan Crommelin and Gerrit Storm",

year = "2016",

month = sep,

day = "7",

doi = "10.1038/natrevmats.2016.69",

language = "English",

volume = "1",

journal = "Nature materials",

issn = "1476-1122",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Cancer nanomedicine

T2 - is targeting our target?

AU - Lammers, Twan

AU - Kiessling, Fabian

AU - Ashford, Marianne

AU - Hennink, Wim

AU - Crommelin, Daan

AU - Storm, Gerrit

PY - 2016/9/7

Y1 - 2016/9/7

N2 - Nanomedicine may have a delivery problem. Rigorous, realistic and holistic rethinking is needed to improve nanomedicine performance and increase patient benefit.

AB - Nanomedicine may have a delivery problem. Rigorous, realistic and holistic rethinking is needed to improve nanomedicine performance and increase patient benefit.

KW - METIS-320803

KW - IR-103724

U2 - 10.1038/natrevmats.2016.69

DO - 10.1038/natrevmats.2016.69

M3 - Article

VL - 1

JO - Nature materials

JF - Nature materials

SN - 1476-1122

IS - 9

M1 - 16069

ER -

Cancer nanomedicine: is targeting our target?

Abstract

Keywords

Access to Document

Fingerprint

Cite this